Keros Therapeutics, Inc. — Cash Flow Charts
4 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$108M
Free Cash Flow
$106M
Investing Cash Flow
$-2M
Financing Cash Flow
$-378M
Capex
$2M
Stock Buybacks
$375M
Stock-Based Comp
$29M
D&A
$2M
SBC Allocated Expense
$29M
SBC Unrecognized Cost
—